Single-Cell Insights Into Diabetic Retinopathy Mechanisms
- Sponsor
- Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
- Study ID
- NCT06497608
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
This study aims to uncover the cellular and molecular mechanisms of diabetic retinopathy through single-cell sequencing to identify new therapeutic targets. The study will collect retinal tissue samples from 3 patients with advanced proliferative diabetic retinopathy who underwent prosthetic eye implantation and 3 normal cadaver donors. Additionally, aqueous humor, vitreous fluid, and plasma samples from patients with severe diabetic retinopathy requiring surgery and macular hole surgery patients without diabetic retinopathy will be analyzed using ELISA, qPCR, and Western Blot. These experiments will validate sequencing results and explore the pathogenesis of diabetic retinopathy to identify potential treatment targets.
Key Dates
- First listed
- Jul 12, 2024
- Start date
- Jul 31, 2024
- Status verified
- Jul 2024
- Primary completion
- Sep 30, 2024
- Completion
- Jul 31, 2027
Study Design
- Enrollment
- 66 participants (estimated)
Arms
- Arm: scRNA_DRPatients with proliferative diabetic retinopathy who underwent prosthetic eye implantation.
- Arm: scRNA_normalBody donors without history of diabetic retinopathy
- Arm: Validate_DRPatients with proliferative diabetic retinopathy (PDR) who underwent vitrectomy surgery
- Arm: Validate_normalPatients who underwent vitrectomy surgery for macular hole (MH) and did not have diabetic retinopathy (DR)
Primary Outcome Measure
Single cell sequencing result [ Time Frame: 1 month ]
Central Contacts
- Yujie Wang, Dr.0061-422510790
Find similar trials
Related Studies
- National Eye Institute Biorepository for Retinal DiseasesRecruiting · National Eye Institute (NEI) · Bethesda, Maryland
- Clinical Applications of Advanced Ophthalmic ImagingRecruiting · University of Miami · Miami, Florida
- Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)Recruiting · University of Alabama at Birmingham · Birmingham, Alabama
- Human iPSC for Repair of Vasodegenerative Vessels in Diabetic RetinopathyRecruiting · University of Alabama at Birmingham · Birmingham, Alabama